Product Information

MATZIM LA 420 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $2.6632 per EA under NDC 52544069530. Its NADAC has been published 517 times since Nov 28, 2013.

FDA first approved this application on Mar 15, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MATZIM LA 420 MG TABLET

Diltiazem Hydrochloride
$2.6632per EA

Strength

420 mg/1

NDC

52544069530

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

DILTIAZEM HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA077686

FDA Approved

3/15/2010

TE Code

AB

On Market Since

3/28/2011

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A4 Inhibitors

Price Statistics

The NADAC for MATZIM LA 420 MG TABLET has been published 517 times since Nov 28, 2013, and over the history we have for it it has declined 32.3%. The table below summarizes its recorded NADAC range and movement.

Current price$2.6632 per EA
All-time high$4.0182 (Jan 13, 2016)
All-time low$2.0522 (Aug 21, 2024)
52-week high$2.7091
52-week low$2.3130
Median price$3.6877
Average price$3.4203
Largest weekly change-15.5% (May 22, 2024)
Weeks tracked517
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+1.2%

3M

+4.8%

6M

+10.6%

1Y

-9.9%

3Y

-20.2%

5Y

-20.2%

All

-32.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MATZIM LA 420 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MATZIM LA 420 MG TABLET, manufactured by Actavis Pharma, Inc., is $2.6632 per EA (NDC 52544069530), effective Nov 11, 2026.

How has the price of MATZIM LA 420 MG TABLET changed over time?

Over the history we have for it, the NADAC for MATZIM LA 420 MG TABLET has declined 32.3%. It has been tracked across 517 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for MATZIM LA 420 MG TABLET?

Since Nov 28, 2013, the NADAC for MATZIM LA 420 MG TABLET has ranged from a low of $2.0522 (Aug 21, 2024) to a high of $4.0182 (Jan 13, 2016), with a median of $3.6877 per EA.

Are there cheaper alternatives to MATZIM LA 420 MG TABLET?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DILTIAZEM 24H ER(LA) 420 MG TB, is $2.4083 per EA — about 10% below MATZIM LA 420 MG TABLET.

Who manufactures MATZIM LA 420 MG TABLET?

MATZIM LA 420 MG TABLET (NDC 52544069530) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.